Morgan Stanley Direct Lending Fund

Q2 net investment income was $38.2 million, or $0.45 per share, versus $0.47 per share in the prior quarter. Total investment income was relatively unchanged at $89 million, while total expenses increased to $50.6 million from $48.6 million. The quarter included $30.2 million of net unrealized appreciation and realized losses, and NAV per share ended at $19.50 versus $19.81 previously. The portfolio was $3.6 billion at fair value, with gross debt-to-equity at 1.21x and unsecured debt at 56% of total funded debt. For Q3 2026, the board declared a $0.45 per share dividend, unchanged from the prior quarter. Management said the dividend was covered by Q2 NII and that the reset dividend level is aligned with normalized earnings power. After quarter end, the company issued $350 million of unsecured notes at a 6.10% coupon to pre-fund part of the February 2027 maturity, which has $425 million outstanding notional.

Michael Occi said the first half of 2026 was a transition period for direct lending, with public market valuations implying a more negative outlook than the portfolio fundamentals justify. He emphasized that the company is staying disciplined on capital allocation, balancing leverage, share repurchases, and JV scaling while maintaining a conservative, defensive posture. His tone was constructive on credit quality and medium-term deployment, noting improved sponsor activity and a strong sourcing advantage inside the Morgan Stanley platform.

David Pessah said the portfolio totaled $3.6 billion at fair value, with 93% in first lien debt and a weighted average loan-to-value of about 39%. He highlighted that the company repurchased about $12.5 million of shares below NAV, while spillover income was about $0.86 per share. On the liability side, he said the company amended and extended its senior secured revolver and completed the $350 million unsecured notes issuance at 6.10%, and that gross debt-to-equity finished at 1.21x, comfortably within target. He also noted the JV had up to $250 million of total equity commitments, with about 52% called to date.

Analysts focused on whether the $0.45 dividend remains safe given lower NII, higher financing costs, and new non-accruals. Management said the quarter reflected offsetting factors: about $0.03 of JV accretion, higher debt expense from higher average leverage, and lost income from non-accruals, but they still felt good about the dividend and the NII base. Questions also covered the new $350 million notes issue, and management said it was effectively swapped to align assets and liabilities. On capital allocation, management described buybacks versus deployment as a balancing act and said the JV ramp is expected to continue over the coming year.